Clinical Trials Logo

Clinical Trial Summary

To detect the effect of sildenafil citrate on Doppler parameters in fetuses suffering from growth restriction to support its use later as prolonged therapy in those pregnancies at higher risk for such complication.


Clinical Trial Description

Participants were randomized in 1:1 ratio into one of the following drug regime:

Group (I): "sildenafil citrate group" This group consisted of 22 women who received single oral dose of 50 mg sildenafil citrate.

Group (II): "placebo group" This group consisted of 22 women who received single oral dose of placebo. All participants were evaluated by ultrasound once they admitted and again after 2-hours following administration of either of the treatment tablets. One sonographer was allocated to evaluate all mothers included in the study. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02362399
Study type Interventional
Source Al Hayat National Hospital
Contact
Status Completed
Phase N/A
Start date March 2015
Completion date April 2016

See also
  Status Clinical Trial Phase
Completed NCT03626597 - Community-based Provision of Urine Pregnancy Tests as Linkage to Reproductive Health Services N/A
Enrolling by invitation NCT01019785 - Vitamin D During In Vitro Fertilisation (IVF) - A Prospective Randomized Trial Phase 3
Recruiting NCT02372487 - Sildenafil Citrate Therapy for Oligohydramnios N/A
Completed NCT00901758 - Intravenous (IV) Nitroglycerin for Versions in Multiparous Women N/A
Recruiting NCT06113237 - Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
Completed NCT01762683 - Influence of Preconceptional Obesity on the Myometrial Cells Differentiation Toward a Contractyl Phenotype N/A